JP2019533642A5 - - Google Patents

Download PDF

Info

Publication number
JP2019533642A5
JP2019533642A5 JP2019513944A JP2019513944A JP2019533642A5 JP 2019533642 A5 JP2019533642 A5 JP 2019533642A5 JP 2019513944 A JP2019513944 A JP 2019513944A JP 2019513944 A JP2019513944 A JP 2019513944A JP 2019533642 A5 JP2019533642 A5 JP 2019533642A5
Authority
JP
Japan
Prior art keywords
optionally substituted
composition
mammal
membered
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019513944A
Other languages
English (en)
Japanese (ja)
Other versions
JP7065081B2 (ja
JP2019533642A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/050964 external-priority patent/WO2018049328A1/en
Publication of JP2019533642A publication Critical patent/JP2019533642A/ja
Publication of JP2019533642A5 publication Critical patent/JP2019533642A5/ja
Application granted granted Critical
Publication of JP7065081B2 publication Critical patent/JP7065081B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019513944A 2016-09-12 2017-09-11 Gpr120モジュレーターとして有用な二環式化合物 Active JP7065081B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662393619P 2016-09-12 2016-09-12
US62/393,619 2016-09-12
PCT/US2017/050964 WO2018049328A1 (en) 2016-09-12 2017-09-11 Bicyclic compounds useful as gpr120 modulators

Publications (3)

Publication Number Publication Date
JP2019533642A JP2019533642A (ja) 2019-11-21
JP2019533642A5 true JP2019533642A5 (enExample) 2020-11-12
JP7065081B2 JP7065081B2 (ja) 2022-05-11

Family

ID=61562078

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019513944A Active JP7065081B2 (ja) 2016-09-12 2017-09-11 Gpr120モジュレーターとして有用な二環式化合物

Country Status (6)

Country Link
US (2) US10865201B2 (enExample)
EP (1) EP3509588B1 (enExample)
JP (1) JP7065081B2 (enExample)
KR (1) KR102539877B1 (enExample)
CN (1) CN110121343B (enExample)
WO (1) WO2018049328A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018049328A1 (en) * 2016-09-12 2018-03-15 Numerate, Inc. Bicyclic compounds useful as gpr120 modulators
KR102537985B1 (ko) 2016-09-12 2023-05-30 인테그랄 헬스 인코퍼레이티드 Gpr120 조정제로서 유용한 단환형 화합물
US20210236443A1 (en) * 2018-04-20 2021-08-05 Krish Biotech Research Private Limited Method of treatment of non-alcoholic steatohepatitis, nash
CN111499592B (zh) * 2020-03-14 2023-06-23 江苏省农用激素工程技术研究中心有限公司 5-氨甲基糖精的合成方法
CN111574414A (zh) * 2020-05-20 2020-08-25 上海毕得医药科技有限公司 一种4-溴-2-甲氧基苯磺酰氯的合成方法
CN114671827B (zh) * 2020-12-24 2024-09-20 杭州百新生物医药科技有限公司 邻苯甲酰磺酰亚胺类衍生物及其应用
CN114685395A (zh) * 2020-12-29 2022-07-01 浙江大学 一种2,3-二氢苯并[d]异噻唑类化合物及其应用
CN117143039B (zh) * 2022-08-29 2026-04-10 山东大学 一种苯并五元氮环类化合物、其制备方法及医药用途
CN116730945B (zh) * 2023-08-10 2023-11-17 北京惠宇乐邦环保科技有限公司 糖精的制备方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2735225A (en) 1956-02-21 Table ix p petri dish tests with x-phthalimido-
DE2253251A1 (de) 1972-10-30 1974-05-09 Thomae Gmbh Dr K Neue phthalimido-sulfonylharnstoffe
DE3474547D1 (en) * 1983-12-02 1988-11-17 Shell Int Research Diphenyl ether herbicides
FR2659327A1 (fr) 1990-03-08 1991-09-13 Centre Nat Rech Scient Derives du benzisothiazolinone-1-dioxyde, utilisables comme inhibiteurs des elastases.
US5350761A (en) * 1991-07-30 1994-09-27 Ciba-Geigy Corporation Indolyl substituted hydroxylamine derivatives
ATE162525T1 (de) * 1991-07-30 1998-02-15 Ciba Geigy Ag Heteroaryl substituierte hydroxylaminderivate als lipoxygenase-inhibitoren
US5334600A (en) * 1991-07-30 1994-08-02 Ciba-Geigy Corporation Isoquinolyl substituted hydroxylamine derivatives
TW219935B (enExample) * 1991-12-25 1994-02-01 Mitsubishi Chemicals Co Ltd
US5599811A (en) * 1995-02-21 1997-02-04 Warner-Lambert Company Benzothiazine dioxides as endothelin antagonists
NZ326874A (en) 1996-03-29 2000-01-28 Pfizer 6-phenylpyridyl-2-amine derivatives
US6716836B2 (en) * 2001-03-22 2004-04-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
GB0124627D0 (en) * 2001-10-15 2001-12-05 Smithkline Beecham Plc Novel compounds
DE10348022A1 (de) 2003-10-15 2005-05-25 Imtm Gmbh Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
TW200613272A (en) * 2004-08-13 2006-05-01 Astrazeneca Ab Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
WO2006038594A1 (ja) * 2004-10-04 2006-04-13 Ono Pharmaceutical Co., Ltd. N型カルシウムチャネル阻害薬
US8110681B2 (en) * 2006-03-17 2012-02-07 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Compounds for the treatment of spinal muscular atrophy and other uses
JP5421783B2 (ja) * 2006-12-27 2014-02-19 サノフイ Rhoキナーゼ阻害剤としての置換イソキノロン及びイソキノリノン誘導体
KR20090113901A (ko) 2007-02-22 2009-11-02 아이알엠 엘엘씨 G 단백질-커플링된 수용체를 조절하기 위한 화합물 및 방법
US8569378B2 (en) 2007-07-20 2013-10-29 Toshiyuki Sakai p27 protein inducer
EA022417B1 (ru) * 2008-10-21 2015-12-30 Саймабэй Терапевтикс, Инк. Арильные агонисты рецептора gpr120 и их применение
AR074760A1 (es) 2008-12-18 2011-02-09 Metabolex Inc Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
WO2010104195A1 (en) * 2009-03-11 2010-09-16 Banyu Pharmaceutical Co.,Ltd. Novel isoindolin-1-one derivative
US8314120B2 (en) * 2010-03-30 2012-11-20 Abbott Gmbh & Co. Kg Small molecule potentiators of metabotropic glutamate receptors
US8299117B2 (en) 2010-06-16 2012-10-30 Metabolex Inc. GPR120 receptor agonists and uses thereof
ES2526124T3 (es) 2010-06-16 2015-01-07 Cymabay Therapeutics, Inc. Agonistas del receptor GPR120 y sus usos
TW201200505A (en) * 2010-06-17 2012-01-01 Metabolex Inc GPR120 receptor agonists and uses thereof
JP2014520879A (ja) 2011-07-15 2014-08-25 ファイザー・インク Gpr119調節因子
MX350717B (es) 2011-11-30 2017-09-14 Hoffmann La Roche Nuevos derivados biciclicos de dihidroisoquinolin-1-ona.
CN105073111A (zh) 2012-10-11 2015-11-18 默沙东公司 用作gpr120激动剂的取代的螺哌啶基化合物
KR101942752B1 (ko) 2012-11-05 2019-01-28 주식회사 엘지화학 Gpr120 효능제로서의 티오아릴 유도체
EP2925746A1 (en) 2012-12-03 2015-10-07 F. Hoffmann-La Roche AG Substituted triazole and imidazole compounds
EP2935257B1 (en) * 2012-12-20 2018-02-07 Purdue Pharma LP Cyclic sulfonamides as sodium channel blockers
JP6333355B2 (ja) 2013-03-14 2018-05-30 ヤンセン ファーマシューティカ エヌ.ベー. Gpr120のアゴニストとして有用な二環式ピロール誘導体
KR102422559B1 (ko) 2013-03-14 2022-07-18 얀센 파마슈티카 엔.브이. Gpr120의 작용제로서 유용한 벤조 융합된 헤테로사이클릭 유도체
PT3013796T (pt) 2013-06-27 2020-03-26 Lg Chemical Ltd Derivados biarílicos como agonistas de gpr120
AR099937A1 (es) * 2014-04-04 2016-08-31 Sanofi Sa Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados
DK3140296T3 (en) 2014-05-07 2018-07-23 Bristol Myers Squibb Co PYRROLIDIN GPR40 MODULATORS FOR TREATMENT OF DISEASES SUCH AS DIABETES
SG11201701578YA (en) 2014-08-29 2017-03-30 Chdi Foundation Inc Probes for imaging huntingtin protein
JP6486699B2 (ja) 2015-01-29 2019-03-20 国立大学法人金沢大学 脱水縮合剤
WO2017068412A1 (en) * 2015-10-21 2017-04-27 Otsuka Pharmaceutical Co., Ltd. Benzolactam compounds as protein kinase inhibitors
KR102537985B1 (ko) * 2016-09-12 2023-05-30 인테그랄 헬스 인코퍼레이티드 Gpr120 조정제로서 유용한 단환형 화합물
WO2018049328A1 (en) * 2016-09-12 2018-03-15 Numerate, Inc. Bicyclic compounds useful as gpr120 modulators

Similar Documents

Publication Publication Date Title
JP2019530674A5 (enExample)
JP2019519598A5 (enExample)
RU2470011C2 (ru) Циклоалкиламины, содержащие в качестве заместителя фенил, как ингибиторы обратного захвата моноаминов
JP2018150302A5 (enExample)
JP2020519606A5 (enExample)
JP2011515482A5 (enExample)
JP2013515074A5 (enExample)
JP6091593B2 (ja) 慢性閉塞性肺疾患の急性増悪の治療におけるピラゾール誘導体の使用
JP2020528889A5 (enExample)
TWI881480B (zh) 克立咪唑(clemizole)化合物於預防及治療肝癌之用途
JP2020514318A5 (enExample)
JP2019506430A5 (enExample)
JP2020500862A5 (enExample)
JP2018518537A5 (enExample)
JP2019501133A5 (enExample)
JP2018507886A5 (enExample)
JP2019507781A5 (enExample)
JP2008520589A5 (enExample)
JP2013010793A5 (enExample)
JP2013010792A5 (enExample)
JP2018534348A5 (enExample)
JP2022502500A5 (enExample)
JP2020502047A5 (enExample)
JP2006518381A5 (enExample)
JP2012517446A (ja) S1p5受容体の作動薬および拮抗薬ならびにそれらの使用方法